Purple Biotech (PPBT) Acquisitions (2023)
Purple Biotech's (PPBT) quarterly Acquisitions came in at $3.5 million in Q4 2023, up 199.9% on a QoQ basis from -$3.5 million in Q1 2023.
Purple Biotech (PPBT) Acquisitions (2023) Analysis & Trends
Purple Biotech (PPBT) has 1 years of Acquisitions data on file, last reported at $3.5 million in Q4 2023.
- On a quarterly basis, Acquisitions changed N/A year-over-year to $3.5 million in Q4 2023; TTM through Dec 2023 was -$3549.0, a N/A change from a year earlier, with the FY2023 full-year figure at -$3549.0, changed N/A from the prior year.
- Acquisitions for Q4 2023 stood at $3.5 million, up from -$3.5 million in the prior quarter.
- Over the last five years, Acquisitions for PPBT reached as high as $3.5 million in Q4 2023 and fell as low as -$3.5 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Purple Biotech | 1.33 Bn | 1.33 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 3.55 Mn |
| Mar 31, 2023 | -3.55 Mn |